The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of ciltacabtagene autoleucel ± lenalidomide maintenance in newly diagnosed multiple myeloma with suboptimal response to frontline autologous stem cell transplant: CARTITUDE-2 cohort D.
 
Bertrand Arnulf
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Takeda
Research Funding - Bristol-Myers Squibb; Janssen
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Janssen; Sanofi
 
Tessa Kerre
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Johnson & Johnson/Janssen; Merck; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Takeda (Inst)
 
Mounzer E. Agha
Stock and Other Ownership Interests - GenCart
 
Michel Delforge
Honoraria - Amgen; Bristol-Myers Squibb; Janssen; Sanofi; Stemline Therapeutics
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Sanofi; Stemline Therapeutics
Research Funding - Janssen
 
Ira Braunschweig
No Relationships to Disclose
 
Nishi Shah
No Relationships to Disclose
 
Shambavi Richard
Honoraria - Bristol-Myers Squibb; Janssen
Consulting or Advisory Role - Genentech
Research Funding - C4 Therapeutics; Gracell; Heidelberg Pharma; Janssen
 
Melissa Alsina
Honoraria - Bristol-Myers Squibb; Janssen; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen
Research Funding - Bristol-Myers Squibb; Janssen
 
Hermann Einsele
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Novartis; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Novartis; Roche; Sanofi; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb; Celgene (Inst); GlaxoSmithKline; Janssen (Inst); Novartis; Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen
 
Pankaj Mistry
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Helen Varsos
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Christina Corsale
Employment - Janssen
 
Jordan Mark Schecter
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
 
Kevin C. De Braganca
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Patents, Royalties, Other Intellectual Property - Johnson & Johnson/Janssen
 
Yogesh Jethava
Employment - Janssen
 
Qingxuan Song
Employment - Janssen
 
Mythili Koneru
Employment - Legend Biotech
Leadership - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
 
Muhammad Akram
Employment - Legend Biotech
 
Yaël C Cohen
Honoraria - Bristol-Myers Squibb; Janssen; Roche
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Janssen
Speakers' Bureau - Abbvie; GlaxoSmithKline
Research Funding - Takeda
Travel, Accommodations, Expenses - Sanofi Aventis GmbH
 
Wilfried Roeloffzen
Honoraria - genzyme (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag (Inst)